TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,116 | +101557.1% | 460 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $7 | -12.5% | 460 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $8 | +60.0% | 460 | +46.0% | 0.00% | +33.3% |
| Q4 2022 | $5 | -99.9% | 315 | -31.5% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | 0.0% | 460 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | -14.3% | 460 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $7,000 | +16.7% | 460 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $6,000 | -25.0% | 460 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $8,000 | 0.0% | 460 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $8,000 | -63.6% | 460 | -62.5% | 0.00% | -72.7% |
| Q1 2021 | $22,000 | 0.0% | 1,227 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $22,000 | 0.0% | 1,227 | 0.0% | 0.01% | -8.3% |
| Q3 2020 | $22,000 | -15.4% | 1,227 | -13.8% | 0.01% | -25.0% |
| Q2 2020 | $26,000 | 0.0% | 1,423 | 0.0% | 0.02% | -11.1% |
| Q1 2020 | $26,000 | +4.0% | 1,423 | +10.4% | 0.02% | +12.5% |
| Q4 2019 | $25,000 | +13.6% | 1,289 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $22,000 | -8.3% | 1,289 | -3.3% | 0.02% | -5.9% |
| Q2 2019 | $24,000 | +9.1% | 1,333 | +23.7% | 0.02% | 0.0% |
| Q1 2019 | $22,000 | – | 1,078 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |